Acquiring Company
CardioFocus, Inc.
Acquired Company
Galvanize Therapeutics
MarlboroughSan CarlosInformation TechnologyBiotechnologyMedical Equipment ManufacturingBiotechnologyHealth CareMedical Equipment ManufacturingDescription
CardioFocus, Inc. has announced the acquisition of Galvanize Therapeutics' Electrophysiology Technology division. This strategic move accelerates CardioFocus' development of the HeartLight X4 true single shot pulse field ablation catheter, expands its presence in Europe and the UK, and strengthens its leadership in innovating the next generation of pulsed field technologies for the treatment of cardiac disorders.
Quick answer
CardioFocus, Inc. is acquiring Galvanize Therapeutics, announced January 11, 2024. CardioFocus, Inc. is based in Marlborough, Massachusetts, United States.
- How much did CardioFocus, Inc. pay for Galvanize Therapeutics?
- The deal value was not disclosed.
- What does CardioFocus, Inc. do?
- CardioFocus is a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AFib), the most common heart arrhythmia.
- Where are CardioFocus, Inc. and Galvanize Therapeutics based?
- CardioFocus, Inc. is based in Marlborough, Massachusetts, United States. Galvanize Therapeutics is based in San Carlos, California, United States.
Source: Fundz verified event record.
Other recent acquisitions in Medical Equipment Manufacturing and Medical Equipment Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right (February 16, 2024)
- Novo Holdings to Acquire Catalent (February 5, 2024)
- Synchron Acquires Equity Stake in ACQUANDAS (February 1, 2024)
- Aditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap™ and NeuroEEG™ for Telehealth and Tele-neurology Applications (January 30, 2024)
- Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics (January 18, 2024)
- Avista Capital Partners Acquires Terrats Medical from Miura Partners (February 16, 2024)
Who to call at CardioFocus, Inc., and when
When CardioFocus, Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day CardioFocus, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CardioFocus, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CardioFocus, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CardioFocus, Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Galvanize Therapeutics?
Galvanize Therapeutics was acquired by CardioFocus, Inc., based in Marlborough. The deal was reported on January 11, 2024. CardioFocus is a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AFib), the most common heart arrhythmia. CardioFocus, Inc. is privately held and operates in Information Technology.
When did CardioFocus, Inc. acquire Galvanize Therapeutics?
CardioFocus, Inc.'s acquisition of Galvanize Therapeutics was reported on January 11, 2024. CardioFocus, Inc. has announced the acquisition of Galvanize Therapeutics' Electrophysiology Technology division. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Galvanize Therapeutics do?
Galvanize Therapeutics is developing therapies to deliver life-changing healthcare solutions to patients and their doctors at the convergence of biology, engineering, and care delivery. It is privately held, operating in Biotechnology, and is based in San Carlos.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.